Abstract
The objective of any experiment is to obtain an unbiased and precise estimate of a treatment effect in an efficient manner. Statistical aspects of the design, conduct, and analysis of the experiment play a major role in determining whether this goal is met. We highlight some of the more important statistical issues that pertain to in vivo studies. Particular emphasis is placed on the role of randomization, the number of animals, the utilization of repeated measures data, adjustments for missing data, and dealing with multiple causes of death or treatment failure. The discussion is not intended to be a comprehensive guide to all the statistical issues that can occur in animal experiments. Rather, the objective is to acquaint researchers with components of the experiment that will require careful statistical thought.
Similar content being viewed by others
References
Clarke R: Issues in experimental design and endpoint analysis in the study of experimental cytotoxic agents in vivo in breast cancer and other models. Breast Cancer Res Treat 46:255–278, 1997
Breslow NE, Day NE: Statististical Methods in Cancer Research: Volume I — The Analysis of Case-Control Studies. IARC Scientific Publications No. 32, Lyon, 1980
Breslow NE, Day NE: Statistical Methods in Cancer Research: Volume II — The Design and Analysis of Cohort Studies. IARC Scientific Publications No. 82, Lyon, 1987
Gart JJ, Krewski D, Lee PN, Tarone RE, Wahrendorf J: Statistical Methods in Cancer Research: Volume III — The Design and Analysis of Long-Term Animal Experiments. IARC Scientific Publications No. 79, Lyon, 1986
Gad S, Weil CS: Statistics and Experimental Design for Toxicologists. Telford, Caldwell NJ, 1988
Daniel WW: Biostatistics: A Foundation for Analysis in the Health Sciences (5th Ed.). Wiley, New York, 1991
Brown BW, Brauner C, Chan A, Gutierrez D, Herson J, Lovato J, Polsley J: STPLAN Version 4.0 — Calculations for Sample Sizes and Related Problems. The University of Texas M.D. Anderson Cancer Center, Department of Biomathematics, 1993
Heitjan DF, Derr JA, Satyaswaroop PG: The multisite tumour transplantation model for human endometrial carcinoma: a statistical evaluation. Cell Prolif 25:193–203, 1992
StatXact 3 for Windows — Statistical Software for Exact Nonparametric Inference. CYTEL Software Corporation, Cambridge MA, 1995
Zimmerman DW, Zumbo BD: Parametric alternatives to the Student t-test under violations of normality and homogeneity of variance. Perceptual and Motor Skills 74:835–844, 1992
Zimmerman DW, Zumbo BD: The relative power of parametric and nonparametric statistical methods. In: Keren G, Lewis C (eds) A Handbook of Data Analysis in the Behavioral Sciences: Methodological Issues. Erlbaum, Hillsdale NJ, 1993, pp 481–517
Liang KY, Zeger S: Longitudinal data analysis using generalized linear models. Biometrika 73:13–22, 1986
Liang KY, Zeger S: Regression analysis for correlated data. Annu Rev Pub Health 14:43–68, 1993
Williams DA: Extra-binomial variation in logistic linear models. Appl Statistics 31:144–148, 1982
Liang KY, Hanfelt JJ: On the use of the quasilikelihood method in teratological experiments. Biometrics 50:872–880, 1994
Carroll RJ, Ruppert D, Stefanski LA: Measurement Error in Nonlinear Models. Chapman and Hall, London, 1995
Hanfelt JJ, Liang KY: Approximate likelihoods for generalized linear errors-in-variables models. J Royal Statistical Society B 59:627–637, 1997
Morgan BJT: The Analysis of Quantal Response Data. Chapman and Hall, London, 1992
Breslow NE: Extra-Poisson variation in log-linear models. Appl Statistics 33:38–44, 1984
McCullagh P, Nelder JA: Generalized Linear Models (2nd Ed.). Chapman and Hall, London, 1989
Stephens TC: Measurement of tumor cell surviving fraction and absolute number of clonogens per tumor in excision assays. In: Kallman RF (ed) Robust Tumor Models in Experimental Cancer Therapy. Pergamon, New York, 1987, chapter 21
Hanauske AR, Hilsenbeck SG, Von Hoff DD: Human tumor screening. In: Teicher B (ed) Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval. Humana, Totowa NJ, 1996, chapter 3
Cox DR, Oakes D: Analysis of Survival Data. Chapman and Hall, London, 1984
Kalbfleish JD, Prentice RL: The Statistical Analysis of Failure Time Data. Wiley, New York, 1980
Hay JW, Wolak FA: A procedure for estimating the unconditional cumulative incidence curve and its variability for the human immunodeficiency virus. Appl Statistics 43:599–624, 1994
Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann of Statistics 16:1141–1154, 1988
Aly EEAA, Kochar SC, McKeague IW: Some tests for comparing cumulative incidence functions and cause-specific hazard rates. J Amer Statistical Assoc 89:994–999, 1994
Lin DY: Non-parametric inference for cumulative incidence functions in competing risks studies. Statistics in Med 16:901–910, 1997
Lagakos SW (issue ed): Statistical methods for multiple events data in clinical trials. Statistics in Med 16(8):833–961, 1997
Heiljan DF, Manni A, Santen RJ: Statistical analysis of in vivo tumor growth experiments. J Cancer Res 53:6042–6050, 1993
Diggle PJ, Liang KY, Zeger S: Analysis of Longitudinal Data. Oxford, 1994
Koziol JA, Maxwell DA, Fukushima M, Colmerauer MEM, Pilch, YH: A distribution-free test for tumor-growth curve analyses with application to an animal tumor immunotherapy experiment. Biometrics 37:383–390, 1981
Wei L, Lachin JM: Two-sample asymptotically distribution-free tests for incomplete multivariate observations. J Amer Statistical Assoc 79:653–661, 1984
Wei LJ, Johnson WE: Combining dependent tests with incomplete repeated measurements. Biometrika 72:359–364, 1985
Wu MC, Hunsberger S, Zucker D: Testing for differences in changes in the presence of censoring: parametric and non-parametric methods. Statistics in Med 13:635–646, 1994
Rygaard K, Spang-Thomsen M: Quantitation and Gompertzian analysis of tumor growth. Breast Cancer Res Treat 46:303–312, 1997
Garg ML, Rao BR, Redmond CK: Maximum-likelihood estimation of the parameters of the Gompertz survival function. Appl Statistics 19:152–159, 1970
Franses PH: Fitting a Gompertz curve (STMA V35 4508). J Operations Res 45:109–113, 1994
Li LY, et al: Antagonistic mutant FGF-2 proteins inhibit angiogenesis and breast cancer xenograft tumorigenesis. Proc Amer Assoc Canc Res Special Conference on Breast Cancer, Keystone CO, 1997
Machado SG, Robinson GA: A direct, general approach based on isobolograms for assessing the joint action of drugs in pre-clinical experiments. Statistics in Med 13:2289–2309, 1994
Leonessa F, Jacobson M, Boyle B, Lippman J, McGarvey M, Clarke R: Effect of tamoxifen on the multidrug-resistant phenotype in human breast cancer cells: isobologram, drug accumulation, and Mr 170,000 glycoprotein (gpl170) binding studies. J Cancer Res 54:441–447, 1994
CARD for Windows: Computer Aided Research and Development by S-Matrix. Westing Software, Corte Madera CA, 1997
Peto R: Guidelines on the analysis of tumour rates and death rates in experimental animals. Br J Cancer 29:101–105, 1974
Little RJA: Modeling the drop-out mechanism in repeated-measures studies. J Am Statistical Assoc 90:1112–1121, 1995
Wu MC, Bailey KR: Estimation and comparison of changes in the presence of informative right censoring: conditional linear model. Biometrics 45:939–955, 1989
Mori M, Woodworth GG, Woolson RF: Application of empirical Bayes inference to estimation of rate of change in the presence of informative right censoring. Statistics in Med 11:621–631, 1992
Mori M, Woolson RF, Woodworth GG: Slope estimation in the presence of informative right censoring: modeling the number of observations as a geometric random variable. Biometrics 50:39–50, 1994
Barnhart HX, Sampson AR: Multiple population models for multivariate random length data — with applications in clinical trials. Biometrics 51:195–204, 1995
Robins JM, Rotnitzky A, Zhao LP: Analysis of semiparametric regression models for repeated outcomes in the presence of missing data. J Am Statistical Assoc 90:106–121, 1995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hanfelt, J.J. Statistical approaches to experimental design and data analysis of in vivo studies. Breast Cancer Res Treat 46, 279–302 (1997). https://doi.org/10.1023/A:1005946614343
Issue Date:
DOI: https://doi.org/10.1023/A:1005946614343